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Generation of restriction 
endonucleases barcode map 
to trace SARS‑CoV‑2 origin 
and evolution
Federico Colombo*, Elisa Corsiero*, Myles J. Lewis  & Costantino Pitzalis
Since the first report of SARS‑CoV‑2 in China in 2019, there has been a huge debate about the origin. 
In this work, using a different method we aimed to strengthen the observation that no evidence of 
genetic manipulation has been found by (1) detecting classical restriction site (RS) sequence in human 
SARS‑CoV‑2 genomes and (2) comparing them with other recombinant SARS‑CoV‑like virus created 
for experimental purposes. Finally, we propose a novel approach consisting in the generation of a 
restriction endonucleases site map of SARS‑CoV‑2 and other related coronavirus genomes to be used 
as a fingerprint to trace the virus evolution.
Coronaviruses (CoVs) goes into the family Coronaviridae causing symptoms primarily in the upper respiratory 
tracts which range from common cold to severe to fatal  illnesses1. They have been associated with two major 
disease outbreaks, the severe acute respiratory syndrome (SARS-CoV, 2002) and the Middle East respiratory 
syndrome (MERS-CoV, 2012)2. In December 2019, a new coronavirus (SARS-CoV-2) started to cause viral 
pneumonia bringing to severe and fatal infection. Although SARS-CoV-2 belongs to the same lineage of CoVs 
that causes SARS, it is genetically different and it cluster apart exploiting phylogenetic  trees3. Phylogenetic 
analysis demonstrated the highly similarity between human SARS-CoV-2 and the sequence isolated from the 
Bat-Cov-raTG134 (97.2% identity) and the Pangolin-SARS-CoV5 (80% identity), particularly in the receptor-
binding-domain (RBD) of the S protein, important to mediate binding to human-receptor-angiotensin-con-
verting-enzyme-2 (hACE2)6. The World Health Organization declared a coronavirus disease 2019 (COVID-19) 
pandemic in March 2020. Therefore, one of the major discussions around SARS-CoV-2 has been related to its 
origin with the assumption that SARS-CoV-2 could have been the result of genetic manipulations or spill-over 
from laboratories studying these viruses. In March 2020, Anderson and colleagues published a detailed analysis 
showing that SARS-CoV-2 does not derive from a laboratory  construct7. Although other several coronavirus 
experts have discredited the hypothesis of a man-made  coronavirus8–12, here we aim to present a different method 
based on the analysis of restriction site (RS) sequences in the genome of SARS-Cov-2 to reconstruct its origin 
and follow the new variants.
Results and discussion
What restriction sites (RS) sequence of the viral genome can say: generation of a restriction 
endonucleases barcoding map. During the SARS-CoV epidemic outbreak in 2003, a method called 
reverse genetic to assemble a full-length cDNA of the SARS-CoV-Urbani strain, as a template for manipulation 
of the viral genome, was published to develop and test candidate vaccines and  therapeutics13. This resulted in the 
so-called infectious clone icSARS-CoV containing atypical markers of the wild-type (WT) virus. In particular, 
several Bgl1 RSs were introduced into the icSARS-CoV cDNA, which can be recognized since mutation are 
included in the newly formed cDNA. Figure 1A shows the sequence alignment between the WT SARS-CoV-
Urbani and the icSARS-CoV. We highlighted the sequence containing the Bgl1 RS used to produce icSARS-CoV.
The newly sequences introduced in the recombinant cDNA of SARS-CoV can be used as markers to fol-
low possible virus laboratory spillage. We analysed natural sequences isolated from four different SARS-CoV 
(hCoV-19-Italy-Vr/hSARS-CoV-19-Wuhan/hCoV-19 Pangolin/Bat-Cov-raTG13) to look for Bgl1 RS ‘marker’ 
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(GCCNNNN/NGGC). All the genomes did not contain these sites (Table S1), in particular, the hSARS-CoV-
19-Wuhan and hCoV-19-Italy-Vr.
By analysing the sequences of Bat-CoV-raTG13 and the hCoV-19-Pangolin, we observed that only one 
sequence from SARS-CoV-Urbani (GCC AGC GTGGT) was found in SARS-CoV-2Wu (Wuhan). This is expected 
since the first part of these two genomes show high similarities.
Another recombinant SARS-CoV was produced in 2007 which derived from fifteen passages of the SARS-
CoV-Urbani in BALB/c mouse lungs, therefore it was named Mouse-Adapted (MA)-SARS-CoV14. The identity 
of MA-SARS-CoV compared with the original SARS-CoV-Urbani is 99.97% with only six distinct nucleotides, 
that cannot be used as markers of this recombinant virus since same mutations are naturally acquired by the 
WT-SARS-CoV, as demonstrated from the sequences of other isolated SARS-CoV14. Both the icSARS-CoV and 
the MA-SARS-CoV have become the most widely used recombinant viruses to study SARS-like viruses and no 
specific sequences were found in the human SARS-CoV-2Wu.
In 2008, a consensus sequence called Bat-SCoV (FJ211859) was generated starting from four Bat-SCoVs 
genomes HKU3–1 (DQ022305), HKU3–2 (DQ084200), HKU3–3 (DQ084199), and RP3 (DQ071615)15. The 
full-length Bat-SCoV infectious clone, generated with the method described by Yount et al.13 include in the 
recombinant sequence specific markers such as the Bgl1 RSs. These RSs have specific nucleic base pairs in the “N” 
positions of the recombinant Bat-SCoV (see supplementary Fig. 5 of Becker et al. summarizing all the markers 
 found15). We observed that these specific sequences were all absent (Fig. 1B, Figure S1).
Other markers to identify the origin of SARS‑Cov‑2. In 2008, Ren et al.showed that SARS-like coro-
navirus (SL-CoVs) from horseshoe bat, which has a high similarity to SARS-CoV, differed in the N-terminus 
of the spike protein and particularly in the receptor binding RBS  region16. Therefore, SL-CoVs were not able to 
infect hACE2 expressing cells, but only chimeric viruses expressing the spike protein of the SARS-CoV were 
able to bind the hACE2 which is the functional receptor of SARS-CoV. The authors identified a specific region 
responsible for the virus entrance into hACE2-expressing cells consisting of a minimal region of less than 200 
amino acids. Interestingly, this group showed that chimeric spike proteins, whereby different regions of the 
SARS-CoV BJ01 (BJ01-S) spike were substituted into the spike of the bat SL-CoV (Rp3), and able to bind the 
hACE receptor. We generated in silico two of this chimeric spike (CS) sequences (the  CS424-494 and the  CS45-608), 
and then performed a multiple alignments to check similarities between other spikes identified after 2008, 
including the Bat-Cov-raTG13, the hCoV-19-Pangolin and the human SARS-CoV-2. The similarities of these 
two chimeric spikes are limited in the RBD of the spike (Fig. 1C) and in the polybasic cleavage site (Figure S2). 
Thus, the recombinant spike as possible progenitors of the hSARS-CoV-2 spike sequence can be excluded.
Moreover, we performed a nucleotide blast sequence to find whether these recombinant spikes are found in 
the recently identified SARS-CoV-2 viruses. As shown in Figure S3–S5, we observed that, despite high similari-
ties, many gaps (intended as single base mutations) are present between WT viruses and the recombinant spikes.
The turning point arrived in 2013, when Xing-Yi and colleagues published an important paper showing that 
a WT bat SL-CoV was capable of using hACE2 as an entry receptor, dispelling the observation that no natural 
SL-SARS-CoV were able to use hACE2. Interestingly, the newly identified bat SL-CoV-WIV1 had high sequence 
similarity (99.9% identity) to two other identified WT bat coronaviruses, RsSHC014 and RS3367. This study 
suggested that direct bat-to-human infection is a possible scenario for some bat SL-CoVs. In 2015, Vineet et al.
made a recombinant virus between the spike of the bat coronavirus SHC014 and the mouse-adapted SARS-CoV 
 backbone17 using the well establish reverse genetic  approach13. According to this method, several Bgl1 RSs were 
included into the sequence (Table S2). Moreover, the sequences between the newly mutant SARS-CoV have poor 
sequence similarity to human SARS-CoV-19-Italy-VR and the SARS-CoV-19-Wuhan (Fig. 1D).
Unique restriction sequence sites: a novel approach to track the SARS‑CoV‑2 origin. Exploit-
ing the RS sequences, which are approximately 6–8 base pairs of DNA, as specific markers, we propose an 
alternative way to trace the SARS-CoV-2 origin. This approach consists in the generation of a RS map of SARS-
CoV-2 and the other four related coronavirus genomes. Using the Serial Cloner Restriction Enzyme Library, we 
generated the RS barcoding map based on the frequency of finding specific RS sequences in the genome. First, 
we generated a RS barcoding map which was used as genetic fingerprinting of the specific sequence analysed and 
which easily highlights sequence differences between the genomes. The pattern of the barcode’s reconstruction 
demonstrated high similarity between the coronavirus isolated from the Bat-Cov-raTG13 and the Pangolin, sug-
Figure 1.  Analyses of several RSs sequences in natural and recombinant viruses. (A) Alignment between the 
WT SARS-CoV Urbani and the icSARS-CoV. The violet box highlight BglI RSs used to build the recombinant 
icSARS-CoV. The red boxes show the different nucleotides present in the wilt type SARS-CoV Urbani. (B) 
This alignment shows in violet specific markers used to build a recombinant spike between the Bat-SCoVs 
genomes HKU3 and RP3. In the hCoV-19-Italy-VR sequence most of these markers’ sites are not present, while 
are similar to the wilt type virus HKU3 and RP3. (C) Multiple sequence alignment performed with ClustalW 
and visualised with JalView show the poor similarities in the RBD between chimeric Spikes generated in the 
laboratory (line 2 and 4) compared with other SARS-CoV sequences. Despite some small regions are conserved 
the chimeric spikes show single bp mutation (substitution, deletion, insertions) which support natural 
evolutions instead of man-made manipulation. (D) A specific area of the alignment performed between the 
mutant SARS-CoV-Urbani MA15 containing the SHC014 spike with the hCoV-19-Italy-VR and the SARS-
CoV-19 Wuhan. Also, in this case, the recombinant virus shows several nucleotide mutations which exclude the 
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gesting a natural evolution and adaptation of the virus. Different sequences of HIV, SARS-CoV and MERS-CoV 
were used as controls (Fig. 2A and Figure S6).
From the full restriction enzyme barcoding map, we identified in the spike (S) gene a sequence of 300 bp that 
can be used as a barcode to identify the virus and differentiate from others (Fig. 2B and S7). It is also important to 
note that this method allows small mutations between new variants to be appreciated. This approach is low-cost 
and does not require full sequencing of the virus genome and extended analyses conducted by bioinformaticians. 
Indeed, by using a standard PCR reaction to amplify the above mentioned 300 bp spike gene, or simply by using 
real-time PRC products from swab test, and subsequent sequencing of this region, it is possible to generate an 
RS barcode that will give us a low-cost system to follow viral mutation and trace it over subsequent years. This 
would allow more samples to be tracked, especially with the emergence of new variants (English, Brazilian, Afri-
can, etc.) that may potentially be more infectious and other variants for which vaccines may be less  effective18. 
Moreover, this approach can easily be used to discriminate between false negative and false positive which are 
the reasons for important additional socio-economic  disruptions19.
Using the data to generate the full barcode map we performed principal component analysis (PCA) to deter-
mine whether the observed frequency of RSs is related to the hierarchical distance of the genomes analysed. The 
PCA plot shows a cluster formed by the Pangolin, the Bat-Cov-raTG13 and human SARS-CoV-2 (5 different 
sequences including the English, Brazilian, African variant and the isolated sequences in Italy and Wuhan.) 
(Fig. 2C). Nearby we find the cluster formed by the bat SARS-CoV related and other 5 SARS-CoV sequences. 
The HIV genomes and the MERS genomes were used as control and clearly clustered apart showing a greater 
difference in sequence identity from SARS-CoV virus.
In addition, we focalised on informative RSs to perform hierarchical clustering on the heatmap using Pearson 
correlation as the distance metric (Fig. 2D and S8). The heatmap confirms that human SARS-CoV-2 (all the 
variants) and Bat-Cov-raTG13 are closer than hCoV-19 Pangolin and MERS CoV.
Finally, the barcode map of the RSs confirmed the absence of unique sites suggesting that the SARS-CoV-19 
is the product of a natural evolutionary process of single base insertions/deletions or/and recombination.
We then focused on the unique RS sequences used to modify the viral genome. In particular, we analysed 
shared sites between SARS-CoV-19Wu, Bat-Cov-raTG13 and Pangolin-SARS-CoV-19. Only six RS sequences 
were shared between these genomes and their location does not suggest their use. In the Venn diagram shown in 
Fig. 3A, there are 12-shared RS. However, they are only six if we consider that some of these enzymes recognize 
the same sequences. One example is the unique RS sequence recognized by Bsp68I, BtuMI, NruI, RruI found at 
319 bp on the Bat-Cov-raTG13 and shifted at 334 bp on the SARS-CoV-19Wu and the Pangolin-SARS-CoV-19. 
This 15 bp shift is due to single base insertions (Fig. 3B).
Another example is the unique RS sequence GAG CTC recognized by Ecl136II on the SARS-CoV-19 genome 
that is located at 15081 bp, while on the Bat-Cov-raTG13 genome we found two of these sequences, one at 
15080 bp and the other one at 19768 bp. The latter, if it were to be the result of genetic engineering, would 
be predicted to produce a gap of 6 bp, while from the local alignment it is clear that a nucleotide substitution 
occurred from C to T forming the new site (Figure S9A).
Finally, the genomic location of these unique sites does not flank specific ORF. Indeed, engineered RSs are 
typically expected to be at the beginning and at the end of an ORF. Here, all the unique RSs are located inside 
the ORFs (Figure S9B), thus not easily editable by conventional genetic engineering.
Discussion
Here, we analysed the peer-review literature of the SARS-related viruses generated in the laboratory over the 
years used to study the evolution of Coronaviruses and to generate drugs for their treatment. We have demon-
strated through the analysis of RS, that SARS-CoV-2 does not contain peculiar RS or other markers that suggest 
a manipulation deriving from the recombinant viruses known in the literature. Indeed, the use of RS remains 
today the simplest, fastest and safest way to modify and study recombinant DNA. However, it should be men-
tioned that other methods have been used for generating recombinant clones, such as the one called transfor-
mation-associated recombination (TAR)  cloning20. This method has proved effective for engineering large viral 
 DNA21,22 and has only recently been developed for viruses with large RNA genomes exploiting Saccharomyces 
cerevisiae23–25. Also, bacterial artificial chromosomes (BACs) were exploited to manipulate the transmissible 
gastroenteritis coronavirus (TGEV) PUR46-MAD  virus26 and although nowadays other genetic manipulation 
mechanisms are known that allow no traces to be left, such as the use of the Crispr-cas  system27,28, these remain 
more disadvantageous because they require higher technical capacity and higher costs and times. Furthermore, 
according to our knowledge, in the literature, there are no reports of SARS-CoV-2 coronavirus modifications 
through these more sophisticated techniques yet.
Finally, we used RS as markers to build a barcode map that could uniquely identify a particular virus. Recently, 
other authors used mathematical algorithms to find barcodes that identified a particular viral genome and build 
phylogenetic  trees29,30 while Son and colleagues developed a simple method to discriminate SARS-CoV-2 from 
SARS-CoV using one-step RT-PCR followed by restriction fragment length  polymorphism31. Although this 
method, based on only three restriction enzymes, succeeds in distinguishing between SARS-CoV2 and SARS-
CoV, it may not be sensitive to discriminate any mutations outside that region within the virus genome and does 
not allow new variants to be tracked. Guan and colleagues developed an elegant study based on the identifica-
tion of a barcode that allows the SARS-CoV-2 genome to be assigned to 5 different clades, however this process 
requires advanced bioinformatics  skills32. Here instead we have shown that with our method it is sufficient to 
sequence a region of 300 bp to build a specific barcode to distinguish the genome of a virus, included the new 
variants (English, Brazilian and African) and to trace its evolution over time. This would allow us to have useful 
information quickly and economically during the classic tests performed on swabs.
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Figure 2.  RS barcodes map help to determine the distance between different viruses’ genomes. (A) RSs barcode 
map of 7 different virus genomes. The colour scale represents the frequency to find that specific RS in the 
genome after using the Serial Cloner Library using 741 RSs. The hierarchical clustering was performed using 
Pearson correlation as distance metric. It is clear that some barcode patterns highlight similarities between 
related viruses, while other patterns show dissimilarities, such as the case of the HIV, used as control, which 
shows a clear different barcode compared with SARS-CoV-2 genomes. B) RSs barcode map performed on a 
region of 300 bp previously identified from the full map. Here, we compared the two human SARS-CoV-2 
(Wuhan and Italian-VR) with most closed genome of the Bat-RaTG13. The barcode generated easily highlights 
similarities or differences between genomes presenting high genetic similarities. (C) Principal component 
analysis (PCA) plot generated with the frequencies of the RSs, retrieved from each of these genomes, confirms 
same distance between viruses’ genomes. (D) Barcode Heatmap with hierarchical clustering based on the most 
informative RSs showing that Human SARS-CoV-2 and Bat-Cov-RaTG13 are evolutionarily closer than hCoV-
19 Pangolin and MERS CoV. The clustering performed with less RSs confirms that we are still able to generate 
the right distance metric.
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Methods
Genomes used for the study. SARS-CoV-2 Wuhan-Hu-1, GenBank: MN908947.3; SARS-CoV-2-Eng-
lish, Gisaid: EPI_ISL_816718; SARS-CoV-2-African, Gisaid: EPI_ISL_678597; SARS-CoV-2-Brazilian, Gisaid: 
EPI_ISL_792680; SARS-CoV-2-19/Italy/VR (Gisaid accession id: EPI_ISL_422438|2020-03-25); SARS Urbani, 
GenBank: AY278741.1; SARS-CoV TW1, GenBank: AY291451.1; SARS-CoV-2 HKU, GenBank: JN854286.1; 
SARS-CoV-2 ZJ0, GenBank: DQ182595.1; SARS-CoV-2 Tai, GenBank: AY348314.1; HIV-1, GenBank: 
KY580639.1, MT222953.1, AF224507.1, MN703133.1, MH327766.1, KC156130.1; MERS-CoV, NCBI Refer-
ence Sequence: NC_019843.3; MERS-CoV, GenBank: KX034098.1, KT006149.2, KT225476.2, MW086533.1; 
Bat SARS-like Rs4231, GenBank: KY417146.1; Pangolin-CoV, GISAID accession numbers EPI_ISL_410721; Bat 
CoV RaTG13 GenBank: MN996532.1.
All the genomic sequences and recombinant spikes sequences used in this study were generated following the 
materials and methods of the literature taken in considerations and saved in xdna format which is compatible 
with Serial Cloner. The files are available upon request to the authors.
Alignments. The sequences were aligned using Serial Cloner, Blastn  suite33,  ClustalW34 and  Jalview35.
Generation of restriction enzyme barcode. The restriction enzyme map barcode of each genome was 
obtained using Serial Cloner library. Using this software each genome was analysed in order to obtain the fre-
quency of each restriction site to occur in that genome. The total frequencies of all the restriction sites present in 
the library were used to generate the barcode map. The  InteractiVenn36 was used to make Venn diagram.
Genomic distance in bp between restriction enzyme sites. The genomic distance in bp between two 
or more restriction enzymes sites was calculated with serial cloner and then reported graphically using Prism 
GraphPad v8.
Principal component analyses (PCA). PCA analyses was performed on the frequencies of the restriction 
enzymes sites on the different viruses’ genomes and plotted by ggbiplot R-studio. Codes available upon request 
to the authors.
Heatmap and hierarchical clustering. The heatmaps were generated in R-studio by using frequencies of 
the restriction enzymes sites on the different viruses’ genomes. The hierarchical clustering was performed using 
Pearson correlation as distance metric and Ward D clustering algorithm. Codes available upon request to the 
authors.
Figure 3.  Shared restriction sites and their genomic distance. (A) Venn Diagram shows shared RSs between 
genomes of different viruses. (B) Genomic distance in bp of the shared RSs between SARS-CoV-Wu, Bat 
RaTG13 and the hCoV-19 Pangolin.
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300 bp specific region. The 300 bp region was determined analysing the area of major discrepancy (low 
identity) between genomes, in particular between related genomes. This area was identified inside the spike (S) 
region. To generate the barcode map of these 300 bp regions we used the same method used for the full-length 
genomes. Thus, we calculated the frequencies of the restriction sites to generate the heatmap.
Informative sites. As informative sites we chose all those restriction sites that showed strong discrepancy 
in the cut-off frequency between the various genomes. Thus, to give an example, sites that had a high cut-off 
frequency in genome A compared to genome B, or sites unique to genome B that are repeatedly frequent in 
genome A (and vice versa). Then all non-informative sites, designated as those sites equally frequent across 
genomes, were discarded. In total we selected 104 informative sites here listed: "AatII" "AccBSI" "AcyI" "AfeI" 
"AloI" "Aor51HI" "AspA2I" "AsuNHI" "AvrII" "AxyI" "BarI" "BbvCI" "BcgI" "BlnI" "BmtI" "BplI" "BsaHI" "Bse21I" 
"BseYI" "BsiWI" "Bsp19I" "BspOI" "BsrBI" "BssNI" "BstACI" "Bsu36I" "BtgZI" "CchIII" "Cfr9I" "Ecl136II" "Eco32I" 
"Eco47III" "Eco53kI" "Eco81I" "EcoICRI" "EcoRV" "GdiII" "Hin1I" "Hsp92I" "MbiI" "MreI" "NcoI" "NheI" 
"NmeAIII" "Pfl23II" "PfoI" "Psp124BI" "PspLI" "PspOMII" "PsrI" "RpaBI" "SacI" "SauI" "SmaI" "SplI" "Sse232I" 
"SstI" "TspMI" "UcoMSI" "XmaI" "XmaJI" "ZraI" "AasI" "AccIII" "AgeI" "AsiGI" "BsePI" "BshTI" "Bsp13I" "BspEI" 
"BspMII" "BssHII" "CspAI" "DinI" "DrdI" "DseDI" "EciI" "Eco147I" "EgeI" "FspAI" "KasI" "Kpn2I" "KroI" "KspAI" 
"McaTI" "Mly113I" "MroI" "MroNI" "NaeI" "NarI" "NgoMIV" "PacI" "PasI" "PauI" "PceI" "PdiI" "PinAI" "PteI" 
"RceI" "SalI" "SfoI" "SseBI" "SspDI" "StuI". To generate the barcode map of the informative sites we used the 
method described for the full length and the 300 bp region.
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